APPROVAL HAS
BEEN EXTENDED WITH THE UNDERST THAT THE RULE CONTAINING THE
RECORDKEEPING WILL BE PROPOSED FOR RECISSION.
Inventory as of this Action
Requested
Previously Approved
10/31/1983
10/31/1983
1,640
0
0
13,120
0
0
0
0
0
SECTIONS 640.85 AND 640.95 REQUIRE THE
REPORTING OF INFORMATION ON EACH LOT OF NORMAL SERUM ALBUMIN AND
PLASMA PROTEIN FACTION FOR FDA TESTING, EVALUATION, AND OFFICIAL
RELEASE PRIOR TO DISBRIBUTION OF THE LOT BY THE MANUFACTURER. THIS
INFORMATION IS USED TO ENSURE THE SAFETY OF THOSE USING THESE
PRODUCTS.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.